{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:28:58Z","timestamp":1786325338461,"version":"build-2736575974"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572101"],"award-info":[{"award-number":["82572101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117160","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:53:12Z","timestamp":1784397192000},"page":"117160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Human NKG2C+ adaptive NK cells for Cancer immunotherapy"],"prefix":"10.1016","volume":"186","author":[{"given":"Qiao","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2026.117160_bb0005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/eji.1830050208","article-title":"\u201cnatural\u201d killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype","volume":"5","author":"Kiessling","year":"1975","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117160_bb0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ijc.2910160204","article-title":"Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity","volume":"16","author":"Herberman","year":"1975","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2026.117160_bb0015","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1084\/jem.20181454","article-title":"NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing","volume":"216","author":"Prager","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2026.117160_bb0020","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fimmu.2015.00368","article-title":"NK cell-mediated antibody-dependent cellular cytotoxicity in Cancer immunotherapy","volume":"6","author":"Wang","year":"2015","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117160_bb0025","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.4049\/jimmunol.167.10.5574","article-title":"Regulation of IFN-gamma signaling is essential for the cytotoxic activity of CD8(+) T cells","volume":"167","author":"Tau","year":"2001","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117160_bb0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ijc.25350","article-title":"Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis","volume":"128","author":"Briesemeister","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2026.117160_bb0035","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.117160_bb0040","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6437057","article-title":"Research progress on NK cell receptors and their signaling pathways","author":"Chen","year":"2020","journal-title":"Mediators Inflamm. 2020"},{"issue":"5","key":"10.1016\/j.intimp.2026.117160_bb0045","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","article-title":"Human NK cells: surface receptors, inhibitory checkpoints, and translational applications","volume":"16","author":"Sivori","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117160_bb0050","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(00)70060-4","article-title":"DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes","volume":"4","author":"Shibuya","year":"1996","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2026.117160_bb0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.20030788","article-title":"Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule","volume":"198","author":"Bottino","year":"2003","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.intimp.2026.117160_bb0060","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2026.117160_bb0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2016.00262","article-title":"Human circulating and tissue-resident CD56(bright) natural killer cell populations","volume":"7","author":"Melsen","year":"2016","journal-title":"Front. Immunol."},{"issue":"7051","key":"10.1016\/j.intimp.2026.117160_bb0070","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","article-title":"Licensing of natural killer cells by host major histocompatibility complex class I molecules","volume":"436","author":"Kim","year":"2005","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2026.117160_bb0075","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41423-024-01186-2","article-title":"Immune surveillance of cytomegalovirus in tissues","volume":"21","author":"Mihali\u0107","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2026.117160_bb0080","article-title":"Biology and clinical relevance of HCMV-associated adaptive NK cells","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117160_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/v16111746","article-title":"Emerging insights into memory natural killer cells and clinical applications","volume":"16","author":"Koki\u00e7i","year":"2024","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.intimp.2026.117160_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005577","article-title":"Adaptive single-KIR(+)NKG2C(+) NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia","volume":"10","author":"Haroun-Izquierdo","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2026.117160_bb0095","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/s41590-022-01327-7","article-title":"Clonal expansion and epigenetic inheritance of long-lasting NK cell memory","volume":"23","author":"R\u00fcckert","year":"2022","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117160_bb0100","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1084\/jem.20172168","article-title":"ARID5B regulates metabolic programming in human adaptive NK cells","volume":"215","author":"Cichocki","year":"2018","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.intimp.2026.117160_bb0105","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1073\/pnas.0813192106","article-title":"Cytokine-induced memory-like natural killer cells","volume":"106","author":"Cooper","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"24","key":"10.1016\/j.intimp.2026.117160_bb0110","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1182\/blood-2012-04-419283","article-title":"Cytokine activation induces human memory-like NK cells","volume":"120","author":"Romee","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.intimp.2026.117160_bb0115","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/eji.201847931","article-title":"Semaphorin 7A modulates cytokine-induced memory-like responses by human natural killer cells","volume":"49","author":"Ghofrani","year":"2019","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117160_bb0120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbmt.2014.01.006","article-title":"Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells","volume":"20","author":"Leong","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2026.117160_bb0125","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1038\/s41598-021-85960-6","article-title":"Metabolic changes of Interleukin-12\/15\/18-stimulated human NK cells","volume":"11","author":"Terr\u00e9n","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2026.117160_bb0130","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.4049\/jimmunol.1402756","article-title":"Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells","volume":"194","author":"Marquardt","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117160_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111937","article-title":"Single-cell RNA sequencing identifies a population of human liver-type ILC1s","volume":"42","author":"Kr\u00e4mer","year":"2023","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.intimp.2026.117160_bb0140","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1158\/2326-6066.CIR-18-0757","article-title":"Accumulation of tumor-infiltrating CD49a(+) NK cells correlates with poor prognosis for human hepatocellular carcinoma","volume":"7","author":"Sun","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2026.117160_bb0145","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3389\/fimmu.2019.01263","article-title":"NK cells in the human lungs","volume":"10","author":"Hervier","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117160_bb0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bmt.1704086","article-title":"IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I\/II trial","volume":"32","author":"Burns","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2026.117160_bb0155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s13046-021-02089-0","article-title":"Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions","volume":"40","author":"Jung","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.117160_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.732135","article-title":"Current perspectives on \u201coff-the-shelf\u201d allogeneic NK and CAR-NK cell therapies","volume":"12","author":"Heipertz","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117160_bb0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","article-title":"Exploring the NK cell platform for cancer immunotherapy","volume":"18","author":"Myers","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6669","key":"10.1016\/j.intimp.2026.117160_bb0170","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2026.117160_bb0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00005-023-00674-z","article-title":"Activating NKG2C receptor: functional characteristics and current strategies in clinical applications","volume":"71","author":"Siemaszko","year":"2023","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"6","key":"10.1016\/j.intimp.2026.117160_bb0180","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1074-7613(00)80574-9","article-title":"Association of DAP12 with activating CD94\/NKG2C NK cell receptors","volume":"8","author":"Lanier","year":"1998","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2026.117160_bb0185","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/sj.leu.2403266","article-title":"TEL-Syk fusion constitutively activates PI3-K\/Akt, MAPK and JAK2-independent STAT5 signal pathways","volume":"18","author":"Kanie","year":"2004","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.intimp.2026.117160_bb0190","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1002\/1521-4141(200010)30:10<2842::AID-IMMU2842>3.0.CO;2-B","article-title":"Mitogen-activated protein kinase activity is involved in effector functions triggered by the CD94\/NKG2-C NK receptor specific for HLA-E","volume":"30","author":"Carretero","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117160_bb0195","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.4049\/jimmunol.1502438","article-title":"Relationship of NKG2C copy number with the distribution of distinct cytomegalovirus-induced adaptive NK cell subsets","volume":"196","author":"Muntasell","year":"2016","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117160_bb0200","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/infdis\/jix608","article-title":"NKG2C deletion is a risk factor for human cytomegalovirus viremia and disease after lung transplantation","volume":"217","author":"Vietzen","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"19","key":"10.1016\/j.intimp.2026.117160_bb0205","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1182\/bloodadvances.2022008952","article-title":"Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT","volume":"7","author":"van der Ploeg","year":"2023","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.intimp.2026.117160_bb0210","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","article-title":"Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.intimp.2026.117160_bb0215","first-page":"633","article-title":"Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer","volume":"32","author":"Levy","year":"2008","journal-title":"Int. J. Oncol."},{"issue":"41","key":"10.1016\/j.intimp.2026.117160_bb0220","doi-asserted-by":"crossref","first-page":"67360","DOI":"10.18632\/oncotarget.11744","article-title":"HLA-E expression and its clinical relevance in human renal cell carcinoma","volume":"7","author":"Seliger","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.intimp.2026.117160_bb0225","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.4049\/jimmunol.1002629","article-title":"HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients","volume":"185","author":"de Kruijf","year":"2010","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117160_bb0230","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.18632\/oncotarget.6506","article-title":"The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma","volume":"7","author":"Talebian Yazdi","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.intimp.2026.117160_bb0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.21873\/cgp.20311","article-title":"HLA-E and HLA-F are overexpressed in glioblastoma and HLA-E increased after exposure to ionizing radiation","volume":"19","author":"Hrbac","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"issue":"7229","key":"10.1016\/j.intimp.2026.117160_bb0240","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.intimp.2026.117160_bb0245","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Gum\u00e1","year":"2004","journal-title":"Blood"},{"issue":"36","key":"10.1016\/j.intimp.2026.117160_bb0250","doi-asserted-by":"crossref","first-page":"14725","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection","volume":"108","author":"Lopez-Verg\u00e8s","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"24","key":"10.1016\/j.intimp.2026.117160_bb0255","doi-asserted-by":"crossref","first-page":"19930","DOI":"10.18632\/oncotarget.4468","article-title":"Deciphering the biology of NKG2C+ natural killer cells","volume":"6","author":"R\u00f6lle","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2026.117160_bb0260","first-page":"9.50.1","article-title":"Identification of human memory-like NK cells","volume":"79","author":"Kovalenko","year":"2017","journal-title":"Curr. Protoc. Cytom."},{"issue":"10","key":"10.1016\/j.intimp.2026.117160_bb0265","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.4049\/jimmunol.1303211","article-title":"Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus","volume":"192","author":"Hendricks","year":"2014","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117160_bb0270","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","article-title":"Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function","volume":"42","author":"Schlums","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.117160_bb0275","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3389\/fimmu.2017.01976","article-title":"Adaptive natural killer cells integrate Interleukin-18 during target-cell encounter","volume":"8","author":"Hammer","year":"2017","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2026.117160_bb0280","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1128\/JVI.01096-13","article-title":"Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity","volume":"87","author":"Wu","year":"2013","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117160_bb0285","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.immuni.2015.02.013","article-title":"Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals","volume":"42","author":"Lee","year":"2015","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.intimp.2026.117160_bb0290","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1172\/JCI77440","article-title":"IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion","volume":"124","author":"R\u00f6lle","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"22","key":"10.1016\/j.intimp.2026.117160_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228864","article-title":"Deciphering the immunological phenomenon of adaptive natural killer (NK) cells and cytomegalovirus (CMV)","volume":"21","author":"Barnes","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2026.117160_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7110546","article-title":"NK cells from RAG- or DCLRE1C-deficient patients inhibit HCMV","volume":"7","author":"Wu","year":"2019","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.intimp.2026.117160_bb0305","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s12864-022-08689-0","article-title":"HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection","volume":"23","author":"Tarrag\u00f3","year":"2022","journal-title":"BMC Genomics"},{"issue":"9","key":"10.1016\/j.intimp.2026.117160_bb0310","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","article-title":"HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A","volume":"95","author":"Lee","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.intimp.2026.117160_bb0315","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.4049\/jimmunol.174.5.2878","article-title":"Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics","volume":"174","author":"Kaiser","year":"2005","journal-title":"J. Immunol."},{"issue":"18","key":"10.1016\/j.intimp.2026.117160_bb0320","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1073\/pnas.0802736105","article-title":"Structural basis for NKG2A\/CD94 recognition of HLA-E","volume":"105","author":"Kaiser","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.intimp.2026.117160_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181134","article-title":"High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults","volume":"12","author":"Mahapatra","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.117160_bb0330","article-title":"Implications of NKG2A in immunity and immune-mediated diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2026.117160_bb0335","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.4049\/jimmunol.2200384","article-title":"Uterine NK cells ace an \u201ca\u201d in education: NKG2A sets up crucial functions at the maternal-Fetal Interface","volume":"209","author":"Colucci","year":"2022","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2026.117160_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011966","article-title":"NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs","volume":"5","author":"B\u00e9ziat","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.intimp.2026.117160_bb0345","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41590-023-01523-z","article-title":"HLA class I signal peptide polymorphism determines the level of CD94\/NKG2-HLA-E-mediated regulation of effector cell responses","volume":"24","author":"Lin","year":"2023","journal-title":"Nat. Immunol."},{"issue":"15","key":"10.1016\/j.intimp.2026.117160_bb0350","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1093\/emboj\/18.15.4250","article-title":"Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94\/NKG2-a and the activating receptor CD94\/NKG2-C to HLA-E","volume":"18","author":"Val\u00e9s-G\u00f3mez","year":"1999","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.intimp.2026.117160_bb0355","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.celrep.2018.07.069","article-title":"Distinct HLA-E peptide complexes modify antibody-driven effector functions of adaptive NK cells","volume":"24","author":"R\u00f6lle","year":"2018","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.intimp.2026.117160_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114867","article-title":"Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells","volume":"43","author":"Qin","year":"2024","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.intimp.2026.117160_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004441","article-title":"Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells","volume":"10","author":"Luetke-Eversloh","year":"2014","journal-title":"PLoS Pathog."},{"issue":"357","key":"10.1016\/j.intimp.2026.117160_bb0370","doi-asserted-by":"crossref","first-page":"357ra123","DOI":"10.1126\/scitranslmed.aaf2341","article-title":"Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia","volume":"8","author":"Romee","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117160_bb0375","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.smim.2014.03.002","article-title":"The CD94\/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection","volume":"26","author":"L\u00f3pez-Botet","year":"2014","journal-title":"Semin. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117160_bb0380","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1002\/eji.201343773","article-title":"NKG2C zygosity influences CD94\/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus","volume":"43","author":"Muntasell","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117160_bb0385","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s13287-021-02655-5","article-title":"Cytokine-induced memory-like natural killer cells for cancer immunotherapy","volume":"12","author":"Tarannum","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.intimp.2026.117160_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.884648","article-title":"Cytokine-induced memory-like NK cells: from the basics to clinical applications","volume":"13","author":"Terr\u00e9n","year":"2022","journal-title":"Front. Immunol."},{"issue":"96","key":"10.1016\/j.intimp.2026.117160_bb0395","doi-asserted-by":"crossref","first-page":"eadk4893","DOI":"10.1126\/sciimmunol.adk4893","article-title":"Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation","volume":"9","author":"Foltz","year":"2024","journal-title":"Sci. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117160_bb0400","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-transduced natural killer cells in CD19-positive lymphoid Tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.117160_bb0405","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/2326-6066.CIR-16-0296","article-title":"Ex vivo expanded adaptive NK cells effectively kill primary acute lymphoblastic Leukemia cells","volume":"5","author":"Liu","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"10","key":"10.1016\/j.intimp.2026.117160_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105857","article-title":"NKG2C+ NK cells for immunotherapy of glioblastoma multiforme","volume":"23","author":"Murad","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.117160_bb0415","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/cei.12785","article-title":"Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans","volume":"185","author":"Bigley","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"16","key":"10.1016\/j.intimp.2026.117160_bb0420","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1158\/1078-0432.CCR-17-3117","article-title":"Fratricide of NK cells in daratumumab therapy for multiple myeloma overcome by ex vivo-expanded autologous NK cells","volume":"24","author":"Wang","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2026.117160_bb0425","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1158\/1078-0432.CCR-20-3418","article-title":"Adaptive natural killer cells facilitate effector functions of daratumumab in multiple myeloma","volume":"27","author":"Cho","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.intimp.2026.117160_bb0430","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.stem.2021.08.013","article-title":"Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy","volume":"28","author":"Woan","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"16","key":"10.1016\/j.intimp.2026.117160_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169426","article-title":"Selective expansion of NKG2C+ adaptive NK cells using K562 cells expressing HLA-E","volume":"23","author":"Phan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.117160_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2025.10.006","article-title":"Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines","volume":"28","author":"Koki\u00e7i","year":"2026","journal-title":"Cytotherapy"},{"key":"10.1016\/j.intimp.2026.117160_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1481745","article-title":"CD94-driven in vitro expansion of highly functional adaptive NKG2C(+) NKG2A(-) CD57(+) NK cells from CMV(+) healthy donors","volume":"16","author":"Giordano","year":"2025","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117160_bb0450","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1016\/j.ymthe.2021.06.018","article-title":"Anti-NKG2C\/IL-15\/anti-CD33 killer engager directs primary and iPSC-derived NKG2C(+) NK cells to target myeloid leukemia","volume":"29","author":"Chiu","year":"2021","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.117160_bb0455","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12943-022-01672-z","article-title":"NK cells and solid tumors: therapeutic potential and persisting obstacles","volume":"21","author":"Tong","year":"2022","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2026.117160_bb0460","doi-asserted-by":"crossref","first-page":"S338","DOI":"10.1016\/j.bbmt.2018.12.548","article-title":"In vivo persistence and function of adaptive NK cell infusions (FATE-NK100) from CMV seropositive haploidentical related donors","volume":"25","author":"Cooley","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.intimp.2026.117160_bb0465","series-title":"Open label dose escalation trial of an adaptive Natural killer (NK) cell infusion (FATE-NK100) with subcutaneous IL-2 in adults with refractory or relapsed acute myelogenous Leukemia (AML)","year":"2017"},{"key":"10.1016\/j.intimp.2026.117160_bb0470","article-title":"Intraperitoneal delivery of adaptive natural killer (NK) cells (FATE-NK100) with intraperitoneal Interleukin-2 in women with recurrent ovarian, fallopian tube, and primary peritoneal","year":"2017","journal-title":"Cancer"},{"issue":"15_suppl","key":"10.1016\/j.intimp.2026.117160_bb0475","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.6044","article-title":"Apollo: a phase I study of adaptive memory natural killer (NK) cells in recurrent ovarian cancer","volume":"38","author":"Geller","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.117160_bb0480","series-title":"FATE-NK100 as monotherapy and in combination with monoclonal antibody in subjects with advanced solid Tumors","year":"2017"},{"key":"10.1016\/j.intimp.2026.117160_bb0485","article-title":"Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines","author":"Koki\u00e7i","year":"2025","journal-title":"bioRxiv"},{"issue":"20","key":"10.1016\/j.intimp.2026.117160_bb0490","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1158\/0008-5472.CAN-17-0799","article-title":"GSK3 inhibition drives maturation of NK cells and enhances their antitumor activity","volume":"77","author":"Cichocki","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117160_bb0495","doi-asserted-by":"crossref","first-page":"1207276","DOI":"10.3389\/fimmu.2023.1207276","article-title":"Natural killer cell engagers (NKCEs): a new frontier in cancer immunotherapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117160_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70046","article-title":"Natural killer cell engagers: from bi-specific to tri-specific and tetra-specific engagers for enhanced cancer immunotherapy","volume":"14","author":"Zhu","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117160_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.09.010","article-title":"Targeting HLA-E-overexpressing cancers with a NKG2A\/C switch receptor","volume":"6","author":"S\u00e6tersmoen","year":"2025","journal-title":"Med"},{"issue":"6","key":"10.1016\/j.intimp.2026.117160_bb0510","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.4049\/jimmunol.181.6.3784","article-title":"TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells","volume":"181","author":"Trotta","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.117160_bb0515","doi-asserted-by":"crossref","first-page":"4598476","DOI":"10.1155\/2020\/4598476","article-title":"Hypoxia impairs NK cell cytotoxicity through SHP-1-mediated attenuation of STAT3 and ERK Signaling pathways","volume":"2020","author":"Teng","year":"2020","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2026.117160_bb0520","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3389\/fimmu.2018.01859","article-title":"Prostaglandin E2 secreted by thyroid Cancer cells contributes to immune escape through the suppression of natural killer (NK) cell cytotoxicity and NK cell differentiation","volume":"9","author":"Park","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117160_bb0525","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI125916","article-title":"Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming","volume":"129","author":"Merino","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"57","key":"10.1016\/j.intimp.2026.117160_bb0530","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc9801","article-title":"The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation","volume":"6","author":"Holmes","year":"2021","journal-title":"Sci. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117160_bb0535","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1677\/erc.1.01301","article-title":"CXC chemokines located in the 4q21 region are up-regulated in breast cancer","volume":"14","author":"Bi\u00e8che","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117160_bb0540","article-title":"Empowering pancreatic tumor homing with augmented anti-tumor potency of CXCR2-tethered CAR-NK cells","volume":"32","author":"Yoon","year":"2024","journal-title":"Mol Ther Oncol"},{"issue":"12","key":"10.1016\/j.intimp.2026.117160_bb0545","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1089\/jir.2021.0078","article-title":"Engineering NK-92 cell by upregulating CXCR2 and IL-2 via CRISPR-Cas9 improves its antitumor effects as cellular immunotherapy for human Colon Cancer","volume":"41","author":"Gao","year":"2021","journal-title":"J. Interf. Cytokine Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:44:33Z","timestamp":1786322673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926010064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":109,"alternative-id":["S1567576926010064"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117160","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human NKG2C+ adaptive NK cells for Cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117160"}}